Jane E. Cavanaugh
Affiliations: | Pharmacology | Duquesne University, Pittsburgh, PA, United States |
Area:
Aging, Pharmacology, Neuroscience BiologyGoogle:
"Jane Cavanaugh"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Matossian MD, Hoang VT, Burks HE, et al. (2021) Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer. Oncoscience. 8: 64-71 |
| Hoang VT, Matossian MD, La J, et al. (2021) Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation. Journal of Cellular Biochemistry |
| Bhatt AB, Wright TD, Barnes V, et al. (2021) Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer. Translational Oncology. 14: 101046 |
| Hoang VT, Matossian MD, Ucar DA, et al. (2020) ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer. Frontiers in Oncology. 10: 1164 |
| Bhatt A, Wright T, Barnes V, et al. (2020) Abstract 5042: Targeting the ERK5 and ERK1/2 pathways simultaneously induces mesenchymal to epithelial transition in TNBC Tumor Biology |
| Wright TD, Raybuck C, Bhatt A, et al. (2019) Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer. Journal of Cellular Biochemistry |
| Bhatt AB, Gupta M, Hoang VT, et al. (2019) Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer. Frontiers in Oncology. 9: 672 |
| Bhatt A, Wright T, Anna K, et al. (2019) Abstract P5-08-07: Study of diphenylamine analogs as inducers of mesenchymal to epithelial transition in breast cancer Cancer Research |
| Ucar D, Matossian, Hoang-Barnes V, et al. (2019) Abstract P2-03-04: A novel druggable target upstream of Notch: MEK5/ERK5 signaling regulates Jagged-1 and Notch1 expression in triple negative breast cancer stem cells Cancer Research. 79 |
| Bhatt AB, Wright TD, Anna K, et al. (2019) Abstract 1879: Novel diphenylamine analogs induce mesenchymal to epithelial transition and enhance the sensitivity of breast cancer cells to conventional chemotherapeutic agents Cancer Research |